Jonathan Coe

Jonathan Coe serves as the President and CEO of Acoustic Wave Cell Therapy since August 2024, focusing on regenerative cell therapies for stress urinary incontinence. Coe has held the position of President and CEO at Prescient Surgical since October 2012. Additionally, Coe acts as a Strategic Advisor for KēlaHealth, Ultralight, and Noleus Technologies, all while being a partner at BPI, LLC, a firm co-founded to drive innovations in plastic, aesthetics, and surgical oncology. Previous experience includes roles at Fogarty Innovation and Metavention, Inc., where Coe served as Director of Engineering and Founding Technical Lead, along with founding Gradient Denervation Technologies. Coe's educational background includes a Bachelor of Science in Mechanical Engineering from the Massachusetts Institute of Technology and a Master of Science in Mechanical Engineering from Georgia Institute of Technology, along with time at Stanford University.